Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial
- PMID: 17893628
- DOI: 10.1097/01.CCM.0000287526.08794.29
Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial
Abstract
Objective: To study whether lactulose or polyethylene glycol is effective to promote defecation in critically ill patients, whether either of the two is superior, and whether the use of enteral laxatives is related to clinical outcome.
Design: Double-blind, placebo-controlled, randomized study.
Setting: Two tertiary intensive care units.
Patients: Three hundred and eight consecutive patients with multiple organ failure were included when receiving mechanical ventilation and intravenous circulatory support and when defecation did not occur on day 3 after admission.
Interventions: Thrice daily administration of lactulose, polyethylene glycol, or placebo until defecation occurred, to a maximum of 4 days.
Measurements and main results: The number of patients with defecation during the study period was 32 of 103 (31%) for placebo, 76 of 110 (69%) for lactulose, and 70 of 95 (74%) for polyethylene glycol (p = .001 for lactulose and polyethylene glycol vs. placebo). Lactulose and polyethylene glycol-treated patients produced stools after a median of 36 and 44 hrs, respectively, compared with 75 hrs for the placebo group (p = .001 for lactulose and polyethylene glycol vs. placebo). Length of stay in the intensive care unit was a median of 156 hrs for the lactulose group, 190 hrs for the polyethylene glycol group, and 196 hrs for the placebo group (p = .001). Intestinal pseudoobstruction or Ogilvie's syndrome occurred in 4.1% of patients in the placebo group, 5.5% of patients in the lactulose group, and 1.0% of patients in the polyethylene glycol group. There was no difference in hospital mortality. Administration of morphine was associated with a longer time before first defecation, except in the polyethylene glycol group. For all groups, defecation within 6 days after admission was associated with a shorter length of stay.
Conclusions: Both lactulose and polyethylene glycol are more effective in promoting defecation than placebo. Patients receiving polyethylene glycol had a slightly lower incidence of acute intestinal pseudoobstruction, whereas length of stay was shorter in lactulose-treated patients. Morphine administration was associated with delayed defecation except in the polyethylene glycol-treated group. Irrespective of study medication, early defecation was associated with a shorter length of stay.
Comment in
-
Constipation, critical illness and mortality: gut-derived toxidromes--real and now imagined.Crit Care Med. 2008 Sep;36(9):2710-1; author reply 2711. doi: 10.1097/CCM.0b013e318184705b. Crit Care Med. 2008. PMID: 18728498 No abstract available.
Comment on
-
Constipation: does it increase morbidity and mortality in critically ill patients?Crit Care Med. 2007 Dec;35(12):2861-2. doi: 10.1097/01.CCM.0000288093.11633.B3. Crit Care Med. 2007. PMID: 18043207 No abstract available.
Similar articles
-
Osmotic and stimulant laxatives for the management of childhood constipation.Cochrane Database Syst Rev. 2016 Aug 17;2016(8):CD009118. doi: 10.1002/14651858.CD009118.pub3. Cochrane Database Syst Rev. 2016. PMID: 27531591 Free PMC article. Review.
-
Application of Oral Lactulose in Combination With Polyethylene Glycol Electrolyte Powder for Colonoscopy Bowel Preparation in Patients With Constipation.Am J Ther. 2016 Jul-Aug;23(4):e1020-4. doi: 10.1097/MJT.0000000000000351. Am J Ther. 2016. PMID: 26658804 Clinical Trial.
-
[Treatment of chronic constipation in children].Ugeskr Laeger. 2013 Aug 12;175(33):1855-8. Ugeskr Laeger. 2013. PMID: 23937872 Danish.
-
Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial.J Clin Pharmacol. 1997 Oct;37(10):904-7. doi: 10.1002/j.1552-4604.1997.tb04264.x. J Clin Pharmacol. 1997. PMID: 9505981 Clinical Trial.
-
Lactulose versus Polyethylene Glycol for Chronic Constipation.Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007570. doi: 10.1002/14651858.CD007570.pub2. Cochrane Database Syst Rev. 2010. PMID: 20614462 Review.
Cited by
-
Successful Use of Intravenous Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Pediatric Patients.J Pediatr Intensive Care. 2021 Oct 7;13(1):25-31. doi: 10.1055/s-0041-1736335. eCollection 2024 Mar. J Pediatr Intensive Care. 2021. PMID: 38571990 Free PMC article.
-
[Nutrition (therapy) in gastrointestinal failure].Med Klin Intensivmed Notfmed. 2024 May;119(4):296-301. doi: 10.1007/s00063-023-01082-z. Epub 2023 Nov 20. Med Klin Intensivmed Notfmed. 2024. PMID: 37985511 Review. German.
-
Development and validation of a clinical score for early diagnosis of constipation in critically ill children.Sci Rep. 2023 Sep 8;13(1):14822. doi: 10.1038/s41598-023-41674-5. Sci Rep. 2023. PMID: 37684310 Free PMC article.
-
[Noninvasive intra-abdominal pressure measurement].Med Klin Intensivmed Notfmed. 2022 Nov;117(8):658-666. doi: 10.1007/s00063-022-00958-w. Epub 2022 Oct 10. Med Klin Intensivmed Notfmed. 2022. PMID: 36214834 German.
-
Epidemiology of constipation in critically ill patients and its impact on in-hospital mortality: a retrospective observational study.J Anesth. 2022 Jun;36(3):349-358. doi: 10.1007/s00540-022-03050-x. Epub 2022 Feb 21. J Anesth. 2022. PMID: 35190868
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
